This amendment adds language requiring the Department of Medical Assistance Services to establish a workgroup to assess and determine a process for Medicaid coverage and reimbursement of emerging technologies and innovative drugs that are approved by the Food and Drug Administration. Language requires the workgroup to report on issues and recommendations to the Joint Subcommittee for Health and Human Resources Oversight by September 1, 2020.